Current Smoker
16
1
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
6.3%
1 terminated out of 16 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Increasing Lung Cancer Screening Among Emergency Department Patients - LCS R01
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
Physical Activity in Promoting Smoking Cessation in African Americans
JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices
Effects of Electronic Cigarette Use on the Lungs
Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households
Strategies to Connect Patients at Federally Qualified Health Clinics With Evidence Based Tobacco Cessation Treatment
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Project MARS: Mobile-Assistance for Regulating Smoking
Quit4Health Intervention in Supporting Smoking Cessation and Preventing Smoking Initiation in Young Adults
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers